News for BrainsWay Ltd. (BRSYF)

Published at

Mar 12, 2025 8:03 AM

by gurufocus.com

positive

positive

BrainsWay Ltd (BRSYF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus on Organic Expansion

Revenue: $11.4 million in Q4 2024, a 27% year-over-year increase; $41 million for full year 2024, a 29% increase from 2023.Gross Margin: 75% in Q4 2024 and for

BWAY.TA BWAY BRSYF

Read more →
Published at

Mar 12, 2025 6:02 AM

by gurufocus.com

neutral

neutral

Q4 2024 Brainsway Ltd Earnings Call Transcript

Mar 11, 2025 / 12:30PM GMTOperator Good day and welcome to the Brainsway fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) Ple

BWAY.TA BWAY BRSYF

Read more →
Published at

Mar 11, 2025 3:17 PM

by seekingalpha.com

neutral

neutral

BrainsWay Ltd. (BWAY) Q4 2024 Earnings Call Transcript

BrainsWay Ltd. (NASDAQ:BWAY) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ETCompany ParticipantsBrian Ritchie - Investor Relations, LifeSci...

BWAY.TA BWAY BRSYF

Read more →
Published at

Mar 11, 2025 2:00 PM

by gurufocus.com

positive

positive

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year 2024 revenue increased nearly 30% YoY to $41 mi

BWAY.TA BWAY BRSYF

Read more →
Published at

Feb 24, 2025 2:00 PM

by gurufocus.com

neutral

neutral

BrainsWay to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

BURLINGTON, Mass. and JERUSALEM, Israel, Feb. 24, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (”BrainsWay” or the ”Company”), a glob

BWAY.TA BWAY BRSYF

Read more →
Published at

Feb 17, 2025 3:15 PM

by zacks.com

neutral

neutral

Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

BWAY.TA BWAY BRSYF

Read more →
Published at

Jan 22, 2025 3:15 PM

by zacks.com

neutral

neutral

Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out?

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

BWAY.TA BWAY BRSYF

Read more →
Published at

Dec 12, 2024 2:12 PM

by manilatimes.net

neutral

neutral

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

**media[490392]**

BWAY.TA BWAY BRSYF

Read more →
Published at

Dec 12, 2024 2:00 PM

by gurufocus.com

neutral

neutral

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (”BrainsWay” or the ”Company”), a global leade

BWAY.TA BWAY BRSYF

Read more →
Published at

Nov 20, 2024 2:00 PM

by gurufocus.com

neutral

neutral

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

Reductions also seen in comorbid anxiety and depression symptoms BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (

BWAY.TA BWAY BRSYF

Read more →
Published at

Nov 12, 2024 6:59 PM

by seekingalpha.com

mixed

mixed

BrainsWay Ltd. (BWAY) Q3 2024 Earnings Call Transcript

BrainsWay Ltd. (NASDAQ:BWAY) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ETCompany ParticipantsBrian Ritchie - IR, LifeSci AdvisorsHadar Levy...

BWAY BWAY.TA BRSYF

Read more →
Published at

Nov 11, 2024 1:13 PM

by gurufocus.com

neutral

neutral

BrainsWay Ltd (XTAE:BWAY) Q3 2024: Everything You Need to Know Ahead of Earnings

BrainsWay Ltd (XTAE:BWAY) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 revenue is $37.27 million, and the earnings

BWAY.TA BWAY BRSYF

Read more →
Published at

Oct 29, 2024 1:20 PM

by manilatimes.net

neutral

neutral

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

**media[450079]**

BWAY.TA BWAY BRSYF

Read more →
Published at

Oct 21, 2024 3:15 PM

by zacks.com

positive

positive

Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

BWAY.TA BWAY BRSYF

Read more →
Published at

Oct 17, 2024 7:13 PM

by gurufocus.com

positive

positive

BrainsWay Ltd (BWAY) Trading 6.25% Higher on Oct 17

Shares of BrainsWay Ltd (BWAY) surged 6.25% in mid-day trading on Oct 17. The stock reached an intraday high of $10.25, before settling at $10.20, up from i

BWAY.TA BWAY BRSYF

Read more →
Published at

Sep 12, 2024 4:41 PM

by seekingalpha.com

mixed

mixed

New additions to Roth MKM’s ADR portfolio for September

Roth MKM analysts updated their top ideas within their ADR universe.

YPFD.BA YPF SONY BGNEN.MX BGNE B1GN34.SA ARGX.BR ARGX ARGNF A1RG34.SA 6160.HK VRNA NNGF.DE NGGTF NGG.BA NGG NG.L MREO MPH.L BWAY.TA BWAY BRSYF 0A9G.L

Read more →
Published at

Aug 17, 2023 11:01 PM

by prnewswire.com

mixed

mixed

Nerve Repair and Regeneration Global Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by 2028 | DelveInsight

/PRNewswire/ -- DelveInsight's Nerve Repair and Regeneration Market Insights report provides the current and forecast market analysis, individual leading nerve...

SYK.MX SYK.DE SYK S1YK34.SA NVRO NPCE MDTN.MX MDT.BA MDT EYESW EYES BSX.MX BSX-PA BSX B1SX34.SA AXGN 2M6.DE 0Y6X.L 0R2S.L 0HOY.L 0HKD.L TYOBY STJ NURO LIVN ECOR BWAY.TA BWAY BRSYF ABTCL.SN ABT.SN ABT 3101.T

Read more →
Published at

Aug 3, 2023 9:01 PM

by marketscreener.com

mixed

mixed

Murchinson Takes Action to Replace Board of Directors of Nano Dimension at Upcoming Annual General Meeting

Highlights Entrenchment Tactics Taken by the Board Before and Following March Special Meeting Where Shareholders Overwhelmingly Supported Murchinson’s Case for Change – Including the Removal of...

SEAC NNDM MCK INSG HCSG HCHC CCURD CCUR 0A92.L 0A52.L BWAY.TA BWAY BRSYF SSYSN.MX SSYS

Read more →
Published at

Jul 12, 2022 8:22 AM

by etfdailynews.com

mixed

mixed

Reviewing BrainsWay (NASDAQ:BWAY) and QHSLab (OTCMKTS:USAQ)

Read Reviewing BrainsWay (NASDAQ:BWAY) and QHSLab (OTCMKTS:USAQ) at ETF Daily News

BWAY.TA BWAY BRSYF USAQ

Read more →
Published at

Jan 18, 2022 7:34 AM

by etfdailynews.com

mixed

mixed

BrainsWay (NASDAQ:BWAY) & Adynxx (OTCMKTS:ADYX) Head to Head Comparison

BrainsWay (NASDAQ:BWAY) and Adynxx (OTCMKTS:ADYX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Valuation & Earnings This table compares BrainsWay and Adynxx’s gross revenue, earnings per share (EPS) and valuation. Gross […]

ADYX BWAY BWAY.TA BRSYF

Read more →